Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma

Journal of Proteome Research

Volumn 6, Issue 5, 2007, Pages 1768-1781

  Yi, Jizu ^a   Kim, Changki ^a   Gelfand, Craig A ^a  

^a BD Technologies   (United States)

Author keywords

Bradykinin; C3 peptides; Inhibition; Mass spectrometry; Proteolysis; Serum and plasma; Stabilization

Indexed keywords

AMINOPEPTIDASE; ANTICOAGULANT AGENT; BRADYKININ; CARBOXYPEPTIDASE; CITRIC ACID; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; EDETIC ACID; HEPARIN; PROTEINASE INHIBITOR;

ARTICLE; BLOOD CELL; BLOOD SAMPLING; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INCUBATION TIME; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NORMAL HUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION;

AMINO ACID SEQUENCE; BLOOD PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMA; PROTEASE INHIBITORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34249315396     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060550h     Document Type: Article

References (35)

1. Anderson, N. L.; Anderson, N. G. The Human Plasma Proteome - History, Character, and Diagnostic Prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
2. Omenn, G. S.; States, D. J.; Adamski, M.; Blackwell, T. W.; Menon, R.; Hermjakob, H.; et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
3. Walsh, P. N.; Ahmad, S. S. Proteases in blood clotting. Essays Biochem. 2002, 38, 95-111.
4. Petricoin, E. F.; Ardekani, A. M.; Hilt, B. A.; Levin, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C; Fishman, D. A.; Kohn, E. C; Lotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
5. Adam, B. L.; Qu, Y.; Davis, J. W.; Ward, M. D.; Clements, M. A.; Cazares, L. H.; Semmes, O. J.; Schellhammer, P. F.; Yasui, Y.; Feng, Z.; Wright, G. L., Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002, 62, 3609-3614.
6. Ebert, M. P. A.; Ebert, M. P.; Meuer, J.; Wiemer, J. C; Schulz, H. U.; Reymond, M. A.; Traugott, U.; Malfertheiner, P.; Rocken, C. Identification of gastric cancer patients by serum protein profiling. J. Proteome Res. 2004, 3, 1261-1266.
7. Ebert, M. P. A.; Niemeyer, D.; Deininger, S. O.; Wrx, T.; Knipping, C.; Hoffmannn, J.; Sauer, J.; Albrecht, W.; MAlfertheiner, P.; Rochen, C. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J. Proteome Res. 2006, 5, 2152-2158.
8. Mor, G.; Visintin, I.; Lai, Y.; Zhao, H.; Schwartz, P.; Rutherford, T.; Yue, L.; Bray-Ward, P.; Ward, D. C. Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 7677-7682.
9. Lin, Y.; Goedgebuure, P. S.; Tan, M. C. B.; Gross, J.; Malone, J. P.; Feng, S.; Larson, J.; Phommaly, C.; Trinkaus, K.; Twonsend, R. R.; Linehan, D. C. Proteins associated with disease and clinical course in pancreas cancer: a proteomic analysis of plasma in surgical patients. J. Proteme Res. 2006, 5, 2169-2176.
10. Zhang, R.; Barker, L.; Pinchev, D.; Marshall, J.; Rasamolisolo, M.; Smith, C.; Kupchak, P.; Kireeva, I.; Ingratta, L.; Jackowski, G. Mining biomarkers in human sera using proteomic tools. Proteomics 2004, 4, 244-256.
11. Abdul-Salam, V. B.; Paul, G. A.; Aji, J. O.; Gibbs, S. R.; Rahman, D.; Taylor, G. W.; Wilkins, M. R.; Edwards, Dr. R. J. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 2006, 6, 2286-2294.
12. Richter, R.; Schulz-Knappe, P.; Schrader, M.; Standker, L.; Jurgens, M.; Tammen, H.; Forssmann, W. G. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J. Chromatogr. B: Biomed. Sci. Appl. 1999, 726, 25-35.
13. Tirumalai, R. S.; Chan, K. C.; Prieto, D. A.; Issaq, H. J.; Conrads, T. C.; Veenstra, T. D. Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2003, 2, 1096-1103.
14. Tammen, H.; Schulte, I.; Hess, R.; Menzel, C.; Kellmann, M.; Mohring, T.; Schulz-Knappe, P. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 2005, 5, 3414-3422.
15. Koomen, J. M.; Li, D.; Xiao, L. C.; Liu, T. C.; Coombes, K. R.; Abbruzzese, J.; Kobayashi, R. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 2005, 4, 972-981.
16. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smitj, C.; Kireeva, I.; Zhang, R.; Takahashi, M.; Stanton, E.; Jackowski, G. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteme Res. 2003, 2, 361-372.
17. Petricoin, E. F.; Ornstein, D. K.; Liotta, L. A. Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol. Oncol. 2004, 22, 322-328.
18. Villanueva, J.; Shaffer, D. R.; Philip, J.; Chaparro, C. A.; Erdjument-Bromage, H.; Olshen, A. B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; Sanchez-Carbayo, M.; Holland, E. C.; Cordon-Cardo, C.; Scher, H. I.; Tempst, P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 2006, 116, 271-284.
19. Check, E. Proteomics and cancer: running before we can walk? Nature 2004, 429, 496-497.
20. Ransohoff, D. F. Lessons from controversy: ovarian cancer screening and serum proteomics. J. Natl. Cancer Inst. 2005, 97, 315-319.
21. Diamandis, E. P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 2004, 3, 367-378.
22. Gillette, M. A.; Mani, D. R.; Carr, S. A. Place of pattern in proteomic biomarker discovery. J. Proteome Res. 2005, 4, 1143-1154.
23. Coombes, K. R.; Morris, J. S.; Hu, J.; Edmonson, S. R.; Baggerly, K. A. Serum proteomics profiling - a young technology begins to mature. Nat. Biotechnol. 2005, 23, 291-292.
24. Villanueva, J.; Philip, J.; Chaparro, C. A.; Li, Y.; Toledo-Crow, R.; DeNoyer, L.; Fleisher, M.; Robbins, R.; Tempst, P. Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
25. Hulmes, J. D.; Bethea, D.; Ho, K.; Huang, S-P.; Ricci, D. L.; Optiteck, G. J.; Hefta, S. A. An Intestigation of Plasma Collection, Stabilization, and Storage Procedures for Proteomic Analysis of Clinical Samples. Clin. Proteomics J. 2004, 1, 17-31.
26. Rai, A. J.; Gelfand, C. A.; Haywood, B. C.; Warunek, D. J.; Yi, J.; Schuchard, M. D.; Mehigh, R. J.; Cockrill, S. L.; Scott, G. B.; Tammen, H.; Schulz-Knappe, P.; Speicher, D. W.; Vitzthum, F.; Haab, B. B.; Siest, G.; Chan, D. W. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 2005, 5, 3262-3277.
27. Rouy, D.; Ernens, I.; Jeanty, C.; Wangner, D. R. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal. Biochem. 2005, 338, 294-298.
28. Banks, R. E.; Stanley, A.; Cairns, D. A.; Barrett, J. H.; Clarke, P.; Thompson, D.; Selby, P. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin. Chem. 2005, 51, 1637-1649.
29. Hsieh, S-Y.; Chen, R-K.; Pan, Y-H.; Lee, H-L. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 2006, 6, 3189-3198.
30. Villanueva, J.; Martorella, A. J.; Lawlor, K.; Philip, J.; Fleisher, M.; Robbins, R. J.; Tempst, P. Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age. Mol. Cell. Proteomics 2006, 5, 1840-1852.
31. Diamandis, E. P. Peptidomics for cancer diagnosis: present and future. J. Proteome Res. 2006, 5, 2079-2082.
32. Sims, P. J.; Wiedmer, T. In HEMATOLOGY, Basic Principles and Practice, 3rd ed; Hoffman, R., Benz, E. J., Jr., Shattil, S. J., Furie, B., Cohen, H. J., Silberstein, L. E., McGlave, P., Eds; Churchill Livingstone: Philadelphia, PA, 2000; pp 651-666.
33. Pellacani, A.; Brunner, H. R.; Nussberger, J. Antagonizing and measurement: approaches to understanding of hemodynamic effects of kinins. J. Cardiovasc. Pharmacol. 1992, 20(Suppl 9), S28-34.
34. Campbell, D. J. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Braz. J. Med. Biol. Res. 2000, 33, 665-677.
35. Moreau, A. E.; Garbacki, N.; Molinaro, G.; Brown, N. J.; Marceau, F.; Adam, A. The kallikrein-kinin system: current and future pharmacological targets. J. Pharmacol. Sci. 2005, 99, 6-38.